Product Information
CLIND PH-BENZOYL PERO 1.2-2.5% is a generic product labeled by Actavis Pharma, Inc., priced at $0.7668 per GM under NDC 00591391668. Its NADAC has been published 349 times since Oct 23, 2019.
Strength
25; 10 mg/g; mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00591391668
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA205128On Market Since
2/19/2019
Pharmacological Classes
Price Statistics
The NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has been published 349 times since Oct 23, 2019, and over the history we have for it it has declined 89.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7668 per GM |
|---|---|
| All-time high | $7.4004 (Mar 11, 2020) |
| All-time low | $0.7668 (Jun 17, 2026) |
| 52-week high | $1.2008 |
| 52-week low | $0.7668 |
| Median price | $1.3083 |
| Average price | $1.7222 |
| Largest weekly change | +71.0% (Feb 22, 2023) |
| Weeks tracked | 349 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Clindamycin phosphate and benzoyl peroxide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLIND PH-BENZOYL PERO 1.2-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PERO 1.2-2.5%, manufactured by Actavis Pharma, Inc., is $0.7668 per GM (NDC 00591391668), effective Jun 24, 2026.
How has the price of CLIND PH-BENZOYL PERO 1.2-2.5% changed over time?
Over the history we have for it, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has declined 89.6%. It has been tracked across 349 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PERO 1.2-2.5%?
Since Oct 23, 2019, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has ranged from a low of $0.7668 (Jun 17, 2026) to a high of $7.4004 (Mar 11, 2020), with a median of $1.3083 per GM.
Are there cheaper alternatives to CLIND PH-BENZOYL PERO 1.2-2.5%?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLIND PH-BENZOYL PERO 1.2-2.5%, so no direct lower-cost alternative is listed.
Who manufactures CLIND PH-BENZOYL PERO 1.2-2.5%?
CLIND PH-BENZOYL PERO 1.2-2.5% (NDC 00591391668) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification